Beyond the March Blahs: How Vitamin D Supports Mental Wellness

The science behind why late winter hits so hard  - and what you can do about it.

There's a reason March feels like the hardest month. After weeks of cold temperatures, grey skies, and limited daylight, many Canadians find themselves in a familiar slump - low energy, flattened mood, and a persistent sense that spring can't come fast enough. We call it the "March Blahs," or seasonal affective disorder (SAD), and while it's tempting to chalk it up to cabin fever, the biology behind it is real and measurable.

One key factor? Vitamin D - or more precisely, the cumulative deficiency that arises from  Canadian winters. Understanding this connection gives you an evidence-based tool to support your wellbeing before spring arrives.

The Vitamin D–Brain Connection

Most Canadians associate vitamin D with bone health - and rightly so. But its role in brain function is equally significant and far less discussed. Vitamin D is not simply a nutrient; it behaves more like a hormone, with receptors found in virtually every tissue in the body, including neurons, the cells of the brain and nervous system.

Vitamin D receptors (VDRs) are distributed throughout brain regions involved in mood regulation and emotional processing, including the hypothalamus, prefrontal cortex, and limbic system.¹ When the active form of vitamin D, 1,25-dihydroxyvitamin D, binds to these receptors, it plays a direct role in regulating the synthesis of serotonin - the neurotransmitter most closely associated with mood stability, emotional resilience, and feelings of wellbeing.

The Serotonin and Dopamine Link

Serotonin (5-HT) is a crucial neurotransmitter, critically involved in mood regulation, and memory as well as immune responses.² Serotonin is also used for melatonin production, which governs our sleep-wake cycle or circadian rhythm.³

Vitamin D is also a potent regulator of dopamine, another neurotransmitter also known as the "feel-good" hormone, which influences the reward centre of your brain, affecting your ability to feel motivation and pleasure as well as important functions such as memory and movement.⁴ Vitamin D is especially crucial for the formation of dopamine neurons during development, and those neurons' capacity to release dopamine.⁵

When vitamin D levels fall, the downstream effects can include reduced serotonin synthesis and dopamine release, disrupted circadian rhythm, poorer sleep quality, and the classic cluster of symptoms that define the March Blahs: fatigue, low motivation, difficulty concentrating, and a flattened emotional tone.

A double-blind study found that vitamin D3 supplementation in healthy subjects during late winter significantly enhanced positive mood and showed evidence of reducing negative affect - that is, feelings of distress, low mood, nervousness, and anxiety. The study's authors proposed that seasonal changes in vitamin D3 levels - driven by reduced sun exposure - directly influence brain serotonin and contribute to seasonal mood variation⁶.

From November through March, the sun's angle in Canada is too low for our skin to produce vitamin D - even on sunny days. By March, many Canadians have accumulated months of deficiency.

Why Canada Is Especially Vulnerable

Between approximately November and March, the sun sits at too low an angle for UVB rays to reach the skin at sufficient intensity for vitamin D synthesis. This is true across most of Canada - from Vancouver to Halifax, and especially for communities north of 50° latitude.⁷

What this means in practical terms: regardless of how much time you spend outdoors during those months, your skin is not synthesizing enough vitamin D. Hence, you must rely entirely on dietary sources and supplementation. And for most Canadians, diet alone is not enough.

The Deficiency Gap Is Wider Than Expected

Health Canada recommends a daily dietary intake of 600–800 IU of vitamin D for adults - yet most Canadians don't reach even this threshold through food alone.⁹ And according to ImmunoCeutica's research team, the current recommended levels were established primarily based on bone health, and may not be sufficient to support optimal immune function, neurological health, or mood regulation.

ImmunoCeutica defines vitamin D deficiency as serum vitamin D levels below 50 nmol/L, with insufficient levels falling between 50–75 nmol/L. Research suggests that levels above 75 nmol/L - and potentially higher - may be needed for full immunological and neurological benefit.¹⁰˒¹¹ By late winter, studies consistently show that a significant proportion of the population falls below these thresholds - including Canadian research confirming vitamin D levels drop sharply between November and March.⁸

What the Research Shows

The relationship between vitamin D and mental health has attracted serious scientific attention over the past two decades. Here is what the evidence currently supports:

Vitamin D Deficiency and Depressive Symptoms

Multiple observational studies have found an association between low serum vitamin D levels and an increased risk of depressive symptoms, particularly in populations with limited sun exposure.¹²˒¹³ A 2010 review noted that most individuals with depression have insufficient vitamin D levels and suggested that treatment with vitamin D may offer a simple and cost-effective approach to improving mood outcomes.¹³

Seasonal Affective Disorder (SAD) and Vitamin D

Seasonal Affective Disorder is a clinically recognized form of depression with a recurring winter pattern. It affects an estimated 2–3% of Canadians, with an additional 15% experiencing a milder "subsyndromal" form - what many would recognize as the March Blahs.¹⁴ SAD prevalence is higher at northern latitudes, a pattern consistent with reduced sun exposure and decreased vitamin D synthesis.

Research has found that low serum vitamin D levels are associated with a higher likelihood of SAD and poor mental wellbeing.¹⁵ Given the variability in individual vitamin D status, personalized testing and supplementation remain the most reliable approach.

Vitamin D as a Neurosteroid

Beyond serotonin, researchers have identified that the brain contains its own enzyme (1-alpha-hydroxylase) that converts circulating vitamin D into its active form locally - meaning the brain can directly regulate its own vitamin D activity. This positions vitamin D as a neurosteroid, influencing gene expression, neurodevelopment, neuroprotection, and mood regulation at the cellular level.¹⁶ In fact, vitamin D has even been referred to as the "neglected neurosteroid" because, despite its broad influence on many physiological processes, including brain function, it has only recently begun receiving attention.

Understanding Your Vitamin D Level

One of the most important things to understand about vitamin D is that deficiency is largely invisible. Unlike iron deficiency, which produces obvious fatigue, or vitamin C deficiency, which causes physical symptoms like aches and easy bruising, low vitamin D can quietly undermine your mood, immune function, and energy levels for months without a clear signal.

The only way to know your vitamin D status is to test it. ImmunoCeutica offers two options designed for Canadians:

Home Test Kit: A convenient at-home finger-prick test that delivers lab-accurate results. The kit includes detailed instructions, a lancet, sample collection materials, and a prepaid return envelope. Results include a personalized vitamin D status report, recommendations and participants have access to Dr. Bonnie Mallard's educational lecture on vitamin D testing and supplementation as part of ImmunoCeutica's Canadian Vitamin D Research Project.

Point-of-Care (POC) Testing: Available through participating healthcare practitioners, with results available in approximately 15 minutes. Ideal for those who prefer working directly with a healthcare provider.

What Are Optimal Levels?

The Endocrine Society defines vitamin D deficiency as serum vitamin D below 20 ng/mL (50 nmol/L) and insufficiency as 21–29 ng/mL. Sufficient levels are considered above 30 ng/mL (75 nmol/L). However, ImmunoCeutica's immunology team - founded by researchers at the University of Guelph - notes that these thresholds were established based on skeletal health and may not reflect what is needed for optimal immune and neurological function.¹⁰˒¹¹ Monitoring your level and adjusting accordingly, with healthcare guidance, is the most personalized approach.

Taking Action This March

Vitamin D deficiency is measurable and addressable. Here's where to start:

1. Test, Don’t Guess. You can't supplement strategically without knowing your baseline. ImmunoCeutica's home test kit makes it easy.
2. Supplement with D3 + K2. If deficiency is confirmed, our ImmunoDrops D3 + K2 pairs vitamin D3 with K2 for immune and cardiovascular support. Take it daily with a meal.
3. Get outside. Even 15–20 minutes of morning light supports mood and sleep - independent of vitamin D synthesis.
4. If mood symptoms persist, see your healthcare provider. Vitamin D supports wellness - it is not a treatment for clinical depression.

Key Takeaways

✓ Vitamin D receptors are found throughout the brain, directly influencing serotonin synthesis and mood regulation

✓ From November to March, Canadians cannot produce vitamin D through sun exposure - deficiency accumulates over months

✓ Low vitamin D is associated with increased risk of depressive symptoms and seasonal mood changes 

✓ Health Canada's recommended levels may not be sufficient for optimal immune and neurological function

✓ Testing is the only way to know your actual vitamin D status - ImmunoCeutica's home test kit makes this accessible 

✓ D3 + K2 supplementation supports both mood and immune function; daily dosing is more effective than sporadic intake

Disclaimer: This article is for informational purposes only and is not medical advice. Always consult your healthcare professional before starting any supplement, especially if you have medical conditions or take medications.

 

References

1. Eyles, D.W. (2020). Vitamin D: Brain and Behaviour. JBMR Plus. https://doi.org/10.1002/jbm4.10419
2. Alimohammadi-Kamalabadi et al. (2024). [Serotonin and immune responses]. https://doi.org/10.1002/hsr2.2276
3. Lee et al. (2021). [Serotonin, melatonin and circadian rhythm]. https://doi.org/10.1073/pnas.2113852118
4. Cleveland Clinic. (2022). Dopamine. https://my.clevelandclinic.org/health/articles/22581-dopamine
5. Pertile et al. (2023). [Dopamine neurons and vitamin D]. https://doi.org/10.1111/jnc.15829
6. Lansdowne, A.T.G. & Provost, S.C. (1998). Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology, 135(4), 319–323. https://doi.org/10.1007/s002130050517
7. Palacios, C. & Gonzalez, L. (2014). Is vitamin D deficiency a major global public health problem? Journal of Steroid Biochemistry and Molecular Biology, 144PA, 138–145. https://doi.org/10.1016/j.jsbmb.2013.11.003
8. Government of Canada. (2022). Vitamin D and Calcium: Updated Dietary Reference Intakes. https://open.canada.ca/data/en/dataset/48eb23d1-954b-43a2-af71-2e361e74c188
9. Holick, M.F. et al. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 96(7), 1911–1930. https://doi.org/10.1210/jc.2011-0385
10. Holick, M.F. (2017). The vitamin D deficiency pandemic. Reviews in Endocrine and Metabolic Disorders, 18(2), 153–165. https://doi.org/10.1007/s11154-017-9424-1
11. Berk, M. et al. (2007). Vitamin D deficiency may play a role in depression. Medical Hypotheses, 69(6), 1316–1319. https://doi.org/10.1016/j.mehy.2007.04.001
12. Penckofer, S. et al. (2010). Vitamin D and depression: Where is all the sunshine? Issues in Mental Health Nursing, 31(6), 385–393. https://doi.org/10.3109/01612840903437657
13. Melrose, S. (2015). Seasonal Affective Disorder: An Overview of Assessment and Treatment Approaches. Depression Research and Treatment, 2015, 178564. https://doi.org/10.1155/2015/178564
14. Frandsen, T.B., Pareek, M., Hansen, J.P. & Nielsen, C.T. (2014). Vitamin D supplementation for treatment of seasonal affective symptoms in healthcare professionals: a double-blind randomised placebo-controlled trial. BMC Research Notes, 7, 528. https://doi.org/10.1186/1756-0500-7-528
15. Eyles, D.W. et al. (2005). Vitamin D receptors in the human brain. Journal of Chemical Neuroanatomy, 29(1), 21–30. https://doi.org/10.1016/j.jchemneu.2004.08.006

Reviewed by Erica Johncox, M.Sc., University of Guelph